Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832871 · ClinicalTrials.gov registry record · NA
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
A NA study, sponsored by New Mexico Cancer Research Alliance.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00832871 is a NA study that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 4 participants.
The verdict
NCT00832871, a NA study, was terminated before completion, sponsored by New Mexico Cancer Research Alliance.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to see if mifepristone prevents worsening of your cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the termination of pregnancies. It has not been approved by the Food and Drug Administration for use in the treatment of cancer. It is unlicensed in the United States for your condition. However, previous work has indicated that mifepristone may be useful due to how it works. It is being made available for use in the United States for compassionate use through the Feminist Majority Foundation.
Interventions
- DRUG Mifepristone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2008-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00832871
The ClinicalTrials.gov registry entry for NCT00832871 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifepristone is the first listed.
NCT00832871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00832871 about?
NCT00832871 is a clinical study titled "Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers". The purpose of this study is to see if mifepristone prevents worsening of your cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the termination of pregnancies. It has not been approved by the Food and Drug Administration for use in the...
What is the current status of trial NCT00832871?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2008-11. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00832871?
The interventions under investigation include: Mifepristone (DRUG).
Who is sponsoring clinical trial NCT00832871?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.